AG2R LA Mondiale Gestion D Actifs purchased a new stake in shares of Cigna Group (NYSE:CI – Free Report) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 10,497 shares of the health services provider’s stock, valued at approximately $3,324,000.
Several other hedge funds have also added to or reduced their stakes in the business. Price T Rowe Associates Inc. MD lifted its holdings in Cigna Group by 10.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock valued at $3,966,690,000 after purchasing an additional 1,094,327 shares during the last quarter. Massachusetts Financial Services Co. MA increased its position in Cigna Group by 0.9% during the 1st quarter. Massachusetts Financial Services Co. MA now owns 11,654,993 shares of the health services provider’s stock worth $3,834,493,000 after buying an additional 98,715 shares during the period. Dodge & Cox increased its position in Cigna Group by 1.3% during the 1st quarter. Dodge & Cox now owns 8,889,733 shares of the health services provider’s stock worth $2,924,722,000 after buying an additional 117,125 shares during the period. GQG Partners LLC increased its position in Cigna Group by 21.5% during the 1st quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock worth $1,607,716,000 after buying an additional 865,092 shares during the period. Finally, Parnassus Investments LLC increased its position in Cigna Group by 3.1% during the 1st quarter. Parnassus Investments LLC now owns 2,885,583 shares of the health services provider’s stock worth $949,357,000 after buying an additional 86,602 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft set a $415.00 price objective on Cigna Group and gave the stock a “buy” rating in a research report on Tuesday, August 5th. Wells Fargo & Company lowered their price objective on Cigna Group from $341.00 to $340.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 14th. Royal Bank Of Canada reiterated an “outperform” rating and set a $371.00 price objective on shares of Cigna Group in a research report on Thursday, June 26th. Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday. Finally, Robert W. Baird set a $372.00 price objective on Cigna Group in a research report on Thursday, August 14th. Two research analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, Cigna Group presently has a consensus rating of “Buy” and a consensus target price of $374.76.
Cigna Group Stock Down 1.0%
Shares of NYSE CI opened at $302.71 on Friday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. Cigna Group has a 52 week low of $256.89 and a 52 week high of $370.83. The stock has a market capitalization of $80.80 billion, a P/E ratio of 16.52, a PEG ratio of 0.90 and a beta of 0.48. The stock’s fifty day moving average is $295.47 and its 200 day moving average is $312.00.
Cigna Group (NYSE:CI – Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, topping analysts’ consensus estimates of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company had revenue of $67.13 billion for the quarter, compared to analysts’ expectations of $62.61 billion. During the same quarter last year, the business earned $6.72 earnings per share. Cigna Group’s revenue was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Sell-side analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.
Cigna Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 18th. Investors of record on Thursday, September 4th will be paid a $1.51 dividend. The ex-dividend date of this dividend is Thursday, September 4th. This represents a $6.04 annualized dividend and a yield of 2.0%. Cigna Group’s dividend payout ratio (DPR) is 32.97%.
Insiders Place Their Bets
In related news, insider Nicole S. Jones sold 28,526 shares of the firm’s stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $300.00, for a total value of $8,557,800.00. Following the sale, the insider directly owned 25,648 shares of the company’s stock, valued at $7,694,400. This trade represents a 52.66% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.70% of the stock is owned by company insiders.
About Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Further Reading
- Five stocks we like better than Cigna Group
- How to Calculate Stock Profit
- Tesla’s U.S. Market Is At An 8-Year Low… How Bad Could It Get?
- What Do S&P 500 Stocks Tell Investors About the Market?
- Congress: The Biggest Trades Impacting Markets Today
- Insider Trades May Not Tell You What You Think
- 3 Companies Boosting Buybacks While Others Pull Back
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.